Linagliptin N-Boc Impurity；Boc-Linagliptin；Linagliptin Impurities；Lingaliptin Intermediates
CAS: 668273-75-4
Chemical Formula:C30H36N8O4
Molecular Weight:572.66
Availability: R&D; Commercialization
⬤ CAS No.668273-75-4
⬤ Our Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate |
| CAS No. | 668273-75-4 |
| Chemical Formula | C30H36N8O4 |
| Molecular Weight | 572.66 |
| Related Categories | Lingaliptin Intermediates |
| Density | 1.32±0.1 g/cm3(Predicted) |
| Storage conditions | Refrigerator |
| Solubility | DMSO (slightly soluble, heated), methanol (slightly soluble, sonicated) |
| Acidity coefficient (pKa) | 12.13±0.20(Predicted) |
| Form | Solid |
| Color | Off-white to light yellow |
| Note | For synthetic research only: This product is specially designed and used for chemical synthesis research as an intermediate in drug development, organic synthesis and other chemical research fields. Not for human or clinical use |
| Drug development | Synthetic intermediates of Linagliptin；Drug Impurity Research |
| Chemical reagents and organic synthesis | Organic synthesis intermediates；Pharmaceutical intermediates research |
| Quality Control and Analysis | Drug purity testing；Stability studies（Study the impurities that may be produced during the storage or use of drugs and evaluate the stability and safety of drugs） |
Reliable Global Partner
“Tianming Pharmaceutical has redefined reliability for us. Their ability to deliver high-potency APIs and intermediates under tight deadlines—is unmatched. The team’s transparency in documentation and proactive updates make them a stress-free partner. A true backbone for our operations!”
March 18, 2024
Outstanding Technical Guidance
“Few suppliers align so perfectly with EU GMP requirements. Tianming’s commitment to audit-ready quality systems, batch traceability, and purity consistency has streamlined our production processes. Their diligence eliminates regulatory risks—a rare advantage in today’s market.”
February 15, 2024
Beyond Supplier, A Solutions Partner
“Tianming’s technical team doesn’t just deliver materials—they solve problems. When we faced stability challenges with a niche compound, their scientists proposed a tailored purity adjustment that saved our project timeline. Their agility transforms obstacles into opportunities.”
June 15, 2024
Strategic Growth Ally
“Over 5+ years, Tianming has consistently adapted to our evolving needs—whether scaling volumes or supporting custom synthesis projects. Their ethical pricing models and long-term vision make them more than a vendor; they’re integral to our competitive edge.”
April 27, 2024
This guide reveals why your Pharmaceutical Ingredient List is vital for compliance and innovation. Learn sourcing strategies, quality benchmarks, and 2024 API trend（Attached API list）
Analyzes molecular, manufacturing, and clinical distinctions between orforglipron and Wegovy APIs. Covers stability, scalability, and sourcing strategies for metabolic drug developers.
Analyzes critical quality markers for premium PQQ supplements: disodium salt bioavailability, stability assurance, and manufacturing red flags. Includes GMP production standards.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
